Aberdeen Group
PCVX icon

Aberdeen Group’s Vaxcyte PCVX Stock Holding History

Aberdeen Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.9M Sell
978,969
-796
-0.1% -$43.2K 0.09% 188
2025
Q4 		$45.2M Buy
979,765
+256,972
+36% +$11.5M 0.07% 234
2025
Q3 		$26M Buy
722,793
+297,886
+70% +$9.87M 0.04% 355
2025
Q2 		$13.8M Buy
424,907
+160,170
+61% +$5.25M 0.02% 521
2025
Q1 		$10M Buy
264,737
+39,913
+18% +$3.19M 0.02% 563
2024
Q4 		$18.4M Buy
224,824
+141,994
+171% +$14.1M 0.03% 390
2024
Q3 		$9.46M Sell
82,830
-107,571
-56% -$9.69M 0.02% 533
2024
Q2 		$14.4M Sell
190,401
-3,831
-2% -$261K 0.03% 445
2024
Q1 		$13.3M Hold
194,232
– – 0.03% 502
2023
Q4 		$12.2M Buy
+194,232
New +$10.1M 0.03% 509

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return